Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Change in Acquisitions & Divestments (2020 - 2026)

Amarin Corp Plc\Uk (AMRN) posted quarterly Change in Acquisitions & Divestments of $45.9 million for Q2 2026, down 8.79% year-over-year from $50.3 million in Q2 2025, and up 7.95% quarter-over-quarter from $42.5 million in Q1 2026.

Amarin Corp Plcuk (AMRN) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $45.9 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Change in Acquisitions & Divestments fell 8.79% year-over-year to $45.9 million; the TTM figure through Jun 2026 stood at $192.4 million (down 6.2% YoY), while the FY2025 annual figure was $209.3 million, down 10.09% from the prior year.
  • Change in Acquisitions & Divestments advanced to $45.9 million in Q2 2026 per AMRN's latest filing, from $42.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $113.2 million in Q1 2022 and bottomed at $16.9 million in Q4 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $54.3 million across 5 years, with a median of $53.5 million in 2022.
  • Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 79.42% — and 2024, when it soared 88.38%.
  • Amarin Corp Plc\Uk's Change in Acquisitions & Divestments stood at $16.9 million in 2022, then jumped by 72.19% to $29.1 million in 2023, then surged by 61.45% to $47.0 million in 2024, then advanced by 0.0% to $47.0 million in 2025, then slipped by 2.39% to $45.9 million in 2026.
  • Business Quant data shows AMRN's Change in Acquisitions & Divestments at $45.9 million in Q2 2026, $42.5 million in Q1 2026, and $47.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 45.88 Mn
Jun 30, 2026 45.88 Mn
Mar 31, 2026 42.50 Mn
Mar 31, 2026 42.50 Mn
Dec 31, 2025 47.00 Mn
Dec 31, 2025 47.00 Mn
Sep 30, 2025 57.00 Mn
Sep 30, 2025 57.00 Mn
Jun 30, 2025 50.30 Mn
Jun 30, 2025 50.30 Mn
Mar 31, 2025 55.00 Mn
Mar 31, 2025 55.00 Mn
Dec 31, 2024 47.00 Mn
Dec 31, 2024 47.00 Mn
Sep 30, 2024 52.80 Mn
Sep 30, 2024 52.80 Mn
Jun 30, 2024 71.00 Mn
Jun 30, 2024 71.00 Mn
Mar 31, 2024 62.00 Mn
Mar 31, 2024 62.00 Mn